Release of adriamycin from poly(γ-benzyl-L-glutamate)/poly(ethylene oxide) nanoparticles

International Journal of Pharmaceutics

Volumn 181, Issue 1, 1999, Pages 107-115

  Oh, Injoon ^a   Lee, Kayoung ^c   Kwon, Hye Young ^a   Lee, Yong Bok ^a   Shin, Sang Chul ^a   Cho, Chong Su ^b   Kim, Chong Kook ^b  

^a Chonnam National University   (South Korea)

^b Seoul National University   (South Korea)

^c NONE

Author keywords

Adriamycin; Nanoparticle; Poly( benzyl L glutamate) poly(ethylene oxide); Sustained release

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DETERMINATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMAL ANALYSIS; X RAY DIFFRACTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; EXCIPIENTS; MALE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLUTAMIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; X-RAY DIFFRACTION;

EID: 0032930406     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00012-5     Document Type: Article

References (22)

1. Bahadur P., Sastry N.V., Rao Y.K. Interaction studies of styrene-ethylene oxide block copolymers with ionic surfactants in aqueous solutions. Colloids Surfaces. 29:1988;343-358.
2. Bhargava H.N., Nicolai D.W., Oza B.J. Topical suspensions. Liberman H.A., Rieger M.M., Banker G.S. Pharmaceutical Dosage Forms: Disperse Systems. 2:1996;183-241 Marcel Dekker, New York.
3. Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 116:1995;1-9.
4. Cho C.S., Kim S.W., Komoto T. Synthesis and structural study of an ABA block copolymer consisting of poly(γ-benzyl-L-glutamate) as the A block and poly(ethylene oxide) as the B block. Macromol. Chem. 191:1990;981-991.
5. Cho C.S., Cheon J.B., Jeong Y.I., Kim I.S., Kim S.H., Akaike T. Novel core-shell type thermo-sensitive nanoparticles composed of poly(γ-benzyl-L-glutamate) as the core and poly(N-isopropylacrylamide) as the shell. Macromol. Rapid Commun. 18:1997;361-369.
6. Coffin M.D., McGinity J.W. Biodegradable pseudolatexes: The chemical stability of poly(D,L-lactide) and poly(ε-caprolactone) nanoparticles in aqueous media. Pharm. Res. 9:1992;200-205.
7. Florence A.T., Attwood D. Physicochemical Principles of Pharmacy. 2nd edn:1988;199-208 Chapmann and Hall, Hong Kong.
8. Gao Z., Eisenberg A. A model of micellization for block copolymers in solutions. Macromolecules. 26:1993;7353-7360.
9. Hruska Z., Riess G., Goddard P. Synthesis and purification of a poly(ethylene oxide)-poly(γ-benzyl-L-glutamate) diblock copolymer bearing tyrosine units at the block junction. Polymer. 34:1993;1333-1335.
10. Jeong Y.I., Cheon J.B., Kim S.H., Nah J.W., Lee Y.M., Sung Y.K., Akaike T., Cho C.S. Clonazepam release from core-shell type nanoparticles in vitro. J. Control. Release. 51:1998;169-178.
11. Kataoka K., Kwon G.S., Yokoyama M., Okano T., Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J. Control. Release. 24:1993;119-132.
12. Kwon G., Suwa S., Yokoyama M., Okano T., Sakuri Y., Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Control. Release. 29:1994;17-23.
13. Kwon G.S., Natio M., Yokoyama M., Okano T., Sakurai Y., Kataoka K Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. 12:1995;192-195.
14. Langer K., Stieneker F., Lambrecht G., Mutschler E., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release. Int. J. Pharm. 158:1997;211-217.
15. 14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int. J. Pharm. 106:1994;201-211.
16. Maruyama A., Ishihara T., Kim J.S., Kim S.W., Akaike T. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). Bioconjugate Chem. 8:1997;735-742.
17. Masson V., Maurin F., Devissaguet J.P., Fessi H. Stability of poly(ε-caprolactone) nanospheres in sterile aqueous media. Int. J. Pharm. 139:1996;113-123.
18. Paul M., Fessi H., Laatiris, Boulard Y., Durand R., Deniau M., Astier A. Pentamidine-loaded poly(D,L-lactide) nanoparticles: physicochemical properties and stability work. Int. J. Pharm. 159:1997;223-232.
19. Rolland A. Pharmacokinetics and tissue distribution of doxorubicin-loaded polymethacrylic nanoparticles in rabbits. Int. J. Pharm. 42:1988;145-154.
20. Sinha B.K., Mimnaugh E.G., Rajagopalan S., Myers C.E. Adriamycin activation and oxygen free radical formation in human breast tumor cells: Protective role of glutathione peroxidase in adriamycin resistance. Cancer Res. 49:1989;3844-3848.
21. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51:1991;3229-3236.
22. Zhang Q., Liao G., Wei D., Nagai T. Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles. Int. J. Pharm. 164:1998;21-27.